Petros Pharmaceuticals Overview
- Year Founded
-
2016
- Status
-
Public
- Employees
-
3
- Stock Symbol
-
PTPI
- Investments
-
1
Petros Pharmaceuticals General Information
Description
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. The Company is working towards the goal of becoming an innovator in the emerging self-care market, driving expanded access to key nonprescription pharmaceuticals as Over-the-Counter and nonprescription drug products with additional conditions for nonprescription use (ACNU Products) treatment options. Petros is pursuing the development of a proprietary integrated technology solutions platform containing two components: SaaS, designed to assist pharmaceutical companies in operationalizing and commercializing an Rx-to-OTC switch as an element in the development of an ACNU Product, and a potential Software as a Medical Device component, which guides the consumer in navigating appropriate self-selection or deselection.
Contact Information
Website
www.petrospharma.comCorporate Office
- 1185 Avenue of The Americas
- 3rd Floor
- New York, NY 10036
- United States
Corporate Office
- 1185 Avenue of The Americas
- 3rd Floor
- New York, NY 10036
- United States
Petros Pharmaceuticals Stock Performance
As of 13-Nov-2026, Petros Pharmaceuticals’s current market cap is $110K with 42.4M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $110K | 42.4M | 138K | $0.03 |
Petros Pharmaceuticals Financials Summary
As of 30-Jun-2026, Petros Pharmaceuticals has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | (4,136) | (5,733) | 7,300 | (6,178) |
| Revenue | 0 | 0 | 0 | 5,822 |
| EBITDA | (3,394) | (4,757) | (1,077) | (4,727) |
| Net Income | (3,202) | 1,914 | (14,319) | (8,163) |
| Total Assets | 3,546 | 5,164 | 10,635 | 33,796 |
| Total Debt | 0 | 0 | 0 | 8,277 |
Petros Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Petros Pharmaceuticals Comparisons
Industry
Financing
Details
Petros Pharmaceuticals Competitors (2)
One of Petros Pharmaceuticals’s 2 competitors is Avenir Wellness Solutions, a Formerly VC-backed company based in Oxnard, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Avenir Wellness Solutions | Formerly VC-backed | Oxnard, CA | ||||
| Vivus | Corporate Backed or Acquired | Campbell, CA |
Petros Pharmaceuticals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Petros Pharmaceuticals Acquisitions (1)
Petros Pharmaceuticals’s most recent deal was a Merger/Acquisition with Neurotrope. The deal was made on 02-Dec-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Neurotrope | 02-Dec-2020 | Merger/Acquisition | Drug Discovery |
Petros Pharmaceuticals ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Petros Pharmaceuticals FAQs
-
When was Petros Pharmaceuticals founded?
Petros Pharmaceuticals was founded in 2016.
-
Where is Petros Pharmaceuticals headquartered?
Petros Pharmaceuticals is headquartered in New York, NY.
-
What is the size of Petros Pharmaceuticals?
Petros Pharmaceuticals has 3 total employees.
-
What industry is Petros Pharmaceuticals in?
Petros Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Petros Pharmaceuticals a private or public company?
Petros Pharmaceuticals is a Public company.
-
What is Petros Pharmaceuticals’s stock symbol?
The ticker symbol for Petros Pharmaceuticals is PTPI.
-
What is the current market cap of Petros Pharmaceuticals?
The current market capitalization of Petros Pharmaceuticals is $110K.
-
Who are Petros Pharmaceuticals’s competitors?
Avenir Wellness Solutions and Vivus are competitors of Petros Pharmaceuticals.
-
What is Petros Pharmaceuticals’s annual earnings per share (EPS)?
Petros Pharmaceuticals’s EPS for 12 months was $0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
